Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Repayment or prepayment of debt
To prepay or repay certain outstanding borrowings and term loan facilities of the company along with accrued interest.
General corporate purposes
To meet general corporate expenses, operational requirements, and strategic business initiatives.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
Incorporated in 2006 (originating from a partnership firm established in 1984), Anupam Rasayan India Limited (ARIL) is one of India's leading custom synthesis chemical manufacturers. The company specializes in multi-step synthesis and complex chemical chemistry, producing custom synthesis agrochemical technicals, specialty intermediates, and polymer additive products for global life sciences and chemical corporations. ARIL operates six integrated manufacturing facilities located in Gujarat (four in Sachin GIDC, Surat, and two in Jhagadia GIDC, Bharuch). Its operations feature advanced automated reaction technology and multi-purpose synthesis blocks, enabling multi-stage chemistries such as fluorination, etherification, nitration, and hydrogenation under strict environmental standards. The company maintains long-standing relationships with over 50 multinational corporate clients across Europe, Japan, North America, and China, deriving over 65% of its total revenues from exports. Backed by dedicated R&D facilities approved by DSIR, ARIL continuously expands its active molecule pipeline and commercializes custom synthesis chemistries for agricultural, pharmaceutical, and industrial applications.
Anupam Rasayan India Limited raised ₹224.70 crore from 15 institutional anchor investors on March 10, 2021, allocating 4,048,647 equity shares at ₹555 per share. Key anchor participants included Nomura Funds, Aditya Birla Sunlife Mutual Fund, Fidelity International, Sundaram Mutual Fund, SBI Life Insurance, IIFL Special Opportunities Fund, and Malabar Select Fund.
Source: RHP • Analysis provided for informational purposes
Last Updated: 28 July 2026, 7:14 AM
Established Custom Synthesis Expertise
Demonstrated track record in executing multi-step complex chemistries and process development for multinational life sciences clients.
Long-Standing Relationships with Global Majors
Strong commercial relationships with global chemical companies across Europe, North America, Japan, and Asia-Pacific.
Modern Integrated Manufacturing Infrastructure
Operates six automated manufacturing units across Surat and Bharuch in Gujarat equipped with versatile synthesis blocks.
Focus on High-Margin Specialty Intermediates
Diversified portfolio of custom synthesis agrochemical and specialty chemical molecules with high barriers to entry.
Significant Revenue Concentration in Key Clients
A substantial portion of total revenues depends on orders from top institutional customers and key product lines.
High Indebtedness and Capital Costs
The company carries significant outstanding debt facilities, exposing it to interest rate fluctuations and debt service obligations.
Raw Material Price Volatility and Supply Risks
Fluctuations in key starting material costs or import disruptions for chemical raw materials could impact operating profit margins.
Anupam Rasayan India Limited
Office Nos. 1101 to 1107, 11th Floor, Icon Rio, Behind Icon Business Centre, Dumas Road, Surat - 395007, Gujarat, India
View on Maps →No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.
Strict Environmental and Chemical Safety Regulations
Chemical manufacturing facilities face stringent environmental compliance standards, pollution control norms, and hazardous waste disposal rules.